Please login to the form below

Not currently logged in

pSivida Strengthens board with new non-executive director

Australia-headquartered drug delivery company pSivida has hired Dr Katherine Woodthorpe as a non-executive director.

Australia-headquartered drug delivery company pSivida has hired Dr Katherine Woodthorpe as a non-executive director.

Dr Woodthorpe is CEO of AVCAL (Australian Private Equity and Venture Capital Association) and has an extensive background as a management adviser and director, including working with Australian technology companies seeking venture funding to being a board member of listed companies. She has also consulted with government groups on innovation and commercialisation.

Woodthorpe is also chair of the Antarctic Climate and Ecosystems Cooperative Research Centre, director of Insearch and a council member of the University of Technology Sydney.

pSivida's managing director, Dr Paul Ashton, said: "We are very fortunate to have Katherine join the board. Katherine brings a unique and powerful blend of scientific and business skills that we believe will greatly assist pSivida."

Prior to AVCAL, Woodthorpe worked as a professional non-executive director and management adviser. Her areas of expertise included developing strategies for rapid growth and commercialization of technology products and services.

Stephen Lake, who joined pSivida's board in July 2004 decided to stand down as a director to focus on the launch of a new technology fund in the UK.

6th August 2007


Featured jobs

Subscribe to our email news alerts


Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...